Cargando…

Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?

Detalles Bibliográficos
Autor principal: Pritchard, Kathleen I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005738/
https://www.ncbi.nlm.nih.gov/pubmed/21172080
http://dx.doi.org/10.1186/bcr2747
_version_ 1782194129540743168
author Pritchard, Kathleen I
author_facet Pritchard, Kathleen I
author_sort Pritchard, Kathleen I
collection PubMed
description
format Text
id pubmed-3005738
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30057382010-12-21 Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer? Pritchard, Kathleen I Breast Cancer Res Short Communication BioMed Central 2010 2010-12-20 /pmc/articles/PMC3005738/ /pubmed/21172080 http://dx.doi.org/10.1186/bcr2747 Text en Copyright ©2010 BioMed Central Ltd.
spellingShingle Short Communication
Pritchard, Kathleen I
Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?
title Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?
title_full Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?
title_fullStr Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?
title_full_unstemmed Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?
title_short Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?
title_sort do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005738/
https://www.ncbi.nlm.nih.gov/pubmed/21172080
http://dx.doi.org/10.1186/bcr2747
work_keys_str_mv AT pritchardkathleeni doselectiveserotoninreceptorinhibitorantidepressantsreducetamoxifenseffectivenessandincreasetheriskofdeathfrombreastcancer